Week In Review — Oct. 31

The Week In Review provides an overview of the past week's top healthcare content, including industry news and trends, Mayo Clinic and Mayo Medical Laboratories news and upcoming events.

weekinreview_in

Halloween Safety: Tips for Trick-or-Treaters

It's the time of year for costumes, sweets, and tricks and treats.
Put Halloween safety first with these common-sense tips. Via Mayo Clinic News Network.

Read article

Compound In Cocoa May Reverse Age-Related Memory Loss

A new study in Nature Neuroscience finds that high doses of flavanols – compounds isolated from cocoa – may reverse the normal memory loss that comes with age. The researchers created a drink with very high flavanol content for the study’s participants who ranged from 50 to 69 years old and didn’t suffer from any kind of memory loss other than what you would expect with normal aging. Via Forbes.

Read article

High Milk Intake Associated With Mortality Risk? 

Swedish researchers have found that a high intake of milk may be associated with higher mortality and fracture risks in women and higher mortality risk in men, but they caution against basing any dietary recommendations on their findings, which were published online October 28 in BMJ. Karl Michaëlsson, MD, PhD, professor in medical epidemiology and senior consultant in orthopedic surgery at Uppsala University in Sweden, and colleagues analyzed data on two large Swedish cohorts: one with 61,433 women aged 39 to 74 years and another with 45,339 men aged 45 to 79 years. Via Medscape.

Read article

Why a Quarantine is the Right Idea for Ebola

Statements that quarantine of health care workers exposed to Ebola is not supported by medical science are misguided. It would be true to say that quarantine takes into account the best current medical knowledge, and factors in the vagaries of disease presentation, difficulties with protocols, unpredictable human behavior and the incredible risks involved. Quarantine is not “punishment” — it is the practice of isolating ill, or potentially ill, individuals from others to limit the spread of infection. Via Star Tribune.

Read article

F.D.A. Approves Pfizer’s Trumenba, a Vaccine for a Rare Meningitis

The Food and Drug Administration said on Wednesday that it had approved a vaccine for a dangerous strain of meningitis that caused outbreaks last year at Princeton and the University of California, Santa Barbara. The vaccine, which is made by Pfizer and is to be called Trumenba, is aimed at preventing a variety of bacterial meningitis known as serogroup B. Via NY Times.

Read article

weekinreview_mc

New Home Test Shakes Up Colon Cancer Screening 

Starting Monday, millions of people who have avoided colon cancer screening can get a new home test that's noninvasive and doesn't require the icky preparation most other methods do…The test was approved by the Food and Drug Administration last month and will be offered by prescription at the Mayo Clinic in Minnesota, where it was developed, and soon nationwide. It's called Cologuard and is sold by Exact Sciences Corp. of Madison, Wisconsin. Mayo Clinic and one of its doctors get royalties from the test. Via Yahoo!.

Read article

Mayo Clinic Chosen as Ebola Treatment Center for Minnesota

Mayo Clinic Officials speak out after it's announced they've been chosen as a treatment center for Ebola patients. The Minnesota Department of Health announced a coordinated treatment plan to handle any potential Ebola cases, with Mayo Clinic playing a key role. Saint Marys Campus at Mayo Clinic is one of four hospitals chosen in the state to be an Ebola treatment center, and it's the only one outside of the Twin Cities…. "I'm not surprised we were chosen. We are leaders in patient care. People trust us and I'm glad. They have a reason to trust us," said Amy Williams, M.D. at Mayo Clinic.  Via KAAL.

Read article

New Criteria For The Diagnosis Of Multiple Myeloma And Related Disorders 

The International Myeloma Working Group (IMWG) has issued updated criteria for the diagnosis of multiple myeloma. The criteria have been published in The Lancet Oncology and are ac­com­panied by recommendations for monitoring and updated criteria for other related plasma cell disorders. Via Myeloma Beacon.

Read article

Genetic Tests Dominate Thyroid Meeting

ATA president Hossein Gharib, MD, of the Mayo Clinic in Rochester, Minn., said use of the Asuragen and Veracyte tests has spread more widely than seen at last year's ATA meeting, but clinicians are still determining how best to use them. Via MedPage Today.

Read article

Covering Your Health Special Report: The Truth About Clinical Trials

We’re taking you inside the research labs at Mayo Clinic, where some of the most cutting edge studies are happening as we speak. We’re introducing you to a group of people who have dedicated their lives to making sure the field of medicine moves forward. Some may describe Bob Ledebuhr as a human guinea pig, but ask Bob and he just doesn’t see it that way…“Every year we receive close to 3,000 calls from all around the world of people contacting us about the latest cancer research.” Toni Mangskau is the Clinical Trial’s Referral Coordinator for the cancer center at Mayo Clinic. Via KIMT.

Read article

weekinreview_radio

Diabetes Awareness and Diabetic Eye Disease Month

http://radio.mayoclinic.org/

Call in: 507-282-1234

Twitter: #mayoclinicradio

kschrib

Kelley Schreiber

Kelley Schreiber is a Marketing Channel Manager at Mayo Medical Laboratories. She is the principle editor and writer of Insights and leads social media and direct marketing strategy. Kelley has worked at Mayo Clinic since 2013. Outside of work, you can find Kelley running, traveling, playing with her new kitten, and exploring new foods.